Markel Co. (MKL) Receives $1,200.00 Consensus PT from Analysts

Shares of Markel Co. (NYSE:MKL) have earned an average rating of “Hold” from the eight analysts that are currently covering the company, MarketBeat reports. Five equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. The average twelve-month price target among brokers that have covered the stock in the last year is $1,200.00.

A number of equities analysts recently commented on the stock. ValuEngine upgraded shares of Markel from a “sell” rating to a “hold” rating in a research note on Monday, April 2nd. Argus assumed coverage on shares of Markel in a research note on Wednesday, April 11th. They set a “hold” rating for the company. Zacks Investment Research upgraded shares of Markel from a “hold” rating to a “buy” rating and set a $1,287.00 target price for the company in a research note on Wednesday, April 11th. William Blair upgraded shares of Markel from a “market perform” rating to an “outperform” rating in a research note on Monday, March 19th. Finally, Royal Bank of Canada reiterated a “hold” rating and set a $1,200.00 target price on shares of Markel in a research note on Thursday, February 8th.

How to Become a New Pot Stock Millionaire

In related news, Vice Chairman Steven A. Markel sold 200 shares of the business’s stock in a transaction on Thursday, February 1st. The shares were sold at an average price of $1,143.47, for a total value of $228,694.00. Following the completion of the sale, the insider now directly owns 106,360 shares of the company’s stock, valued at $121,619,469.20. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, insider Alan I. Kirshner sold 100 shares of the business’s stock in a transaction on Monday, April 2nd. The shares were sold at an average price of $1,149.02, for a total transaction of $114,902.00. The disclosure for this sale can be found here. Over the last three months, insiders sold 1,800 shares of company stock valued at $2,023,292. 2.46% of the stock is owned by corporate insiders.

Institutional investors and hedge funds have recently made changes to their positions in the stock. Aevitas Wealth Management Inc. purchased a new stake in Markel in the fourth quarter valued at $108,000. First Personal Financial Services lifted its position in Markel by 156.1% in the fourth quarter. First Personal Financial Services now owns 105 shares of the insurance provider’s stock valued at $120,000 after acquiring an additional 64 shares during the last quarter. SeaCrest Wealth Management LLC purchased a new stake in Markel in the fourth quarter valued at $122,000. Simplex Trading LLC lifted its position in Markel by 169.1% in the fourth quarter. Simplex Trading LLC now owns 148 shares of the insurance provider’s stock valued at $168,000 after acquiring an additional 93 shares during the last quarter. Finally, Cigna Investments Inc. New purchased a new stake in Markel in the fourth quarter valued at $201,000. 78.03% of the stock is owned by hedge funds and other institutional investors.

Shares of MKL stock opened at $1,165.11 on Friday. The company has a debt-to-equity ratio of 0.33, a current ratio of 0.60 and a quick ratio of 0.60. The firm has a market cap of $16,028.85, a P/E ratio of 1,988.07 and a beta of 0.89. Markel has a 12 month low of $936.95 and a 12 month high of $1,194.98.

Markel (NYSE:MKL) last issued its earnings results on Tuesday, February 6th. The insurance provider reported $6.64 EPS for the quarter, missing analysts’ consensus estimates of $8.55 by ($1.91). The firm had revenue of $1.67 billion for the quarter, compared to analyst estimates of $1.58 billion. Markel had a return on equity of 0.39% and a net margin of 6.52%. sell-side analysts anticipate that Markel will post 36.49 earnings per share for the current year.

TRADEMARK VIOLATION NOTICE: “Markel Co. (MKL) Receives $1,200.00 Consensus PT from Analysts” was originally reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this news story on another site, it was copied illegally and republished in violation of international trademark & copyright laws. The legal version of this news story can be read at https://www.dispatchtribunal.com/2018/04/24/markel-co-mkl-receives-1200-00-consensus-pt-from-analysts.html.

About Markel

Markel Corporation, a diverse financial holding company, markets and underwrites specialty insurance products in the United States, the United Kingdom, Canada, and internationally. It operates through three segments: U.S. Insurance, International Insurance, and Reinsurance. The U.S. Insurance segment offers general and professional liability, property, personal line, program, and workers' compensation insurance products, as well as other insurance product lines, such as ocean marine, surety, CPI, and coverages.

Analyst Recommendations for Markel (NYSE:MKL)

Receive News & Ratings for Markel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Markel and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply